{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T20:49:59Z","timestamp":1787690999372,"version":"build-2784847793"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1168749"],"award-info":[{"award-number":["APP1168749"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1194483"],"award-info":[{"award-number":["APP1194483"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003921","name":"Department of Health, Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.semarthrit.2022.151988","type":"journal-article","created":{"date-parts":[[2022,2,27]],"date-time":"2022-02-27T01:09:50Z","timestamp":1645924190000},"page":"151988","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Factors influencing clinician prescribing of disease-modifying anti-rheumatic drugs for inflammatory arthritis: A systematic review and thematic synthesis of qualitative studies"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9772-5272","authenticated-orcid":false,"given":"Aislinn F.","family":"Lalor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0096-0442","authenticated-orcid":false,"given":"Joanne E.","family":"Brooker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3084-746X","authenticated-orcid":false,"given":"Tomas","family":"Rozbroj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7417-7691","authenticated-orcid":false,"given":"Samuel L.","family":"Whittle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine L.","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Rowett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0597-0933","authenticated-orcid":false,"given":"Rachelle","family":"Buchbinder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6836-122X","authenticated-orcid":false,"given":"Denise A.","family":"O'Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2022.151988_bib0001","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update","volume":"79","author":"Smolen","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.semarthrit.2022.151988_bib0002","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/art.41752","article-title":"2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis","volume":"73","author":"Fraenkel","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0003","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/annrheumdis-2020-217159","article-title":"EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update","volume":"79","author":"Gossec","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0004","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/art.40726","article-title":"2018 American College of Rheumatology\/National Psoriasis Foundation guideline for the treatment of psoriatic arthritis","volume":"71","author":"Singh","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0005","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/annrheumdis-2016-210770","article-title":"2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis","volume":"76","author":"van der Heijde","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0006","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/art.41042","article-title":"2019 update of the American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis","volume":"71","author":"Ward","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0007","year":"2022","journal-title":"An Australian Living Guideline for the Pharmacological Management of Inflammatory Arthritis: version 1.2"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0008","article-title":"Effects of glucocorticoids on radiological progression in rheumatoid arthritis","volume":"1","author":"Kirwan","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0009","article-title":"Clinical guideline for the diagnosis and management of early rheumatoid arthritis [Internet]","year":"2009","journal-title":"[Melbourne]"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0010","first-page":"895","article-title":"Suboptimal methotrexate use in rheumatoid arthritis patients in Italy: the MARI study","volume":"33","author":"Idolazzi","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41927-019-0090-7","article-title":"A systematic review of guidelines for managing rheumatoid arthritis","volume":"3","author":"Mian","year":"2019","journal-title":"BMC Rheumatol"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0012","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1136\/annrheumdis-2011-200761","article-title":"Effect of adherence to European treatment recommendations on early arthritis outcome: data from the ESPOIR cohort","volume":"71","author":"Escalas","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0013","first-page":"keab330","article-title":"Patient and rheumatologist perspectives on tapering DMARDs in rheumatoid arthritis: a qualitative study","author":"Hazlewood","year":"2021","journal-title":"Rheumatol"},{"issue":"24","key":"10.1016\/j.semarthrit.2022.151988_bib0014","article-title":"Living a normal life\u201d: a qualitative study of patients\u2019 views of medication withdrawal in rheumatoid arthritis","volume":"3","author":"Baker","year":"2019","journal-title":"BMC Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.151988_bib0015","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1002\/acr.23869","article-title":"Qualitative study of treatment preferences for rheumatoid arthritis and pharmacotherapy acceptance: Indigenous patient perspectives","volume":"72","author":"Loyola-Sanchez","year":"2020","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0016","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/acr.23329","article-title":"Patients' attitudes and experiences of disease-modifying antirheumatic drugs in rheumatoid arthritis and spondyloarthritis: A qualitative synthesis","volume":"70","author":"Kelly","year":"2018","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0017","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s10067-010-1383-9","article-title":"Optimal care for rheumatoid arthritis: a focus group study","volume":"29","author":"Bernatsky","year":"2010","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0018","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13012-014-0153-5","article-title":"Factors influencing rheumatologists\u2019 prescription of biological treatment in rheumatoid arthritis: an interview study","volume":"9","author":"Kalkan","year":"2014","journal-title":"Implement Sci"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0019","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.0 [Internet]","article-title":"Chapter 21: qualitative evidence","author":"Noyes","year":"2019"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0020","series-title":"Cochrane Methods [Internet]","year":"2019"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0021","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1471-2288-12-181","article-title":"Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ","volume":"12","author":"Tong","year":"2012","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0022","unstructured":"Covidence systematic review software, Veritas Health Innovation, Melbourne, Australia. Available from: www.covidence.org."},{"key":"10.1016\/j.semarthrit.2022.151988_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0024","series-title":"Critical Appraisal Skills Programme (CASP) [Internet]","year":"2018"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0025","series-title":"NVivo qualitative data analysis software","year":"2018"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0026","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2288-8-45","article-title":"Methods for the thematic analysis of qualitative research in systematic reviews","volume":"8","author":"Thomas","year":"2008","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001895","article-title":"Using qualitative evidence in decision making for health and social interventions: an approach to assess confidence in findings from qualitative evidence syntheses (GRADE-CERQual)","volume":"12","author":"Lewin","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0028","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1002\/acr.23541","article-title":"Experience and context shape patient and clinician goals for treatment of rheumatoid arthritis: A qualitative study","volume":"70","author":"Barton","year":"2018","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0029","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/acr.23801","article-title":"Qualitative exploration of triangulated, shared decision-making in rheumatoid arthritis","volume":"71","author":"Binder-Finnema","year":"2019","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0030","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1111\/1756-185X.13660","article-title":"Rheumatologists' insight into medication adherence in patients with rheumatoid arthritis: A qualitative study","volume":"22","author":"Heidari","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0031","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/rheumatology\/keh003","article-title":"A survey of British rheumatologists\u2019 DMARD preferences for rheumatoid arthritis","volume":"43","author":"Jobanputra","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0032","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/rheumatology\/kei029","article-title":"Rheumatologists\u2019 judgements about the efficacy of anti-TNF therapy in two neighbouring regions","volume":"44","author":"Kee","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0033","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/acr.23527","article-title":"Ethnographic observational study of the biologic initiation conversation between rheumatologists and biologic-naive rheumatoid arthritis patients","volume":"70","author":"Kottak","year":"2018","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0034","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/1471-2474-14-279","article-title":"Patient's access to healthcare and treatment in rheumatoid arthritis: the views of stakeholders in Portugal","volume":"14","author":"Laires","year":"2013","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0035","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3109\/03009742.2013.863382","article-title":"Factors influencing the prescription of intensive combination treatment strategies for early rheumatoid arthritis","volume":"43","author":"Meyfroidt","year":"2014","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0036","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3899\/jrheum.170773","article-title":"Rheumatologists' views and experiences in managing rheumatoid arthritis in elderly patients: A qualitative study","volume":"45","author":"Nawrot","year":"2018","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0037","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s41927-019-0057-8","article-title":"Intensive management for moderate rheumatoid arthritis: a qualitative study of patients\u2019 and practitioners\u2019 views","volume":"3","author":"Prothero","year":"2019","journal-title":"BMC Rheumatol"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0038","first-page":"539","article-title":"Rheumatologists\u2019 recommended patient information when prescribing methotrexate for rheumatoid arthritis","volume":"28","author":"Thompson","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0039","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1093\/rheumatology\/ken323","article-title":"Discordant perspectives of rheumatologists and patients on COBRA combination therapy in rheumatoid arthritis","volume":"47","author":"van Tuyl","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0040","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2710.2008.00886.x","article-title":"Treatment of pregnant and non-pregnant rheumatic patients: a survey among Dutch rheumatologists","volume":"33","author":"Vroom","year":"2008","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0041","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1136\/annrheumdis-2014-206807","article-title":"EULAR recommendations for patient education for people with inflammatory arthritis","volume":"74","author":"Zangi","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.151988_bib0042","first-page":"529","article-title":"Long-term persistence and adherence on urate-lowering treatment can be maintained in primary care-5-year follow-up of a proof-of-concept study","volume":"56","author":"Abhishek","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.semarthrit.2022.151988_bib0043","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2147\/TCRM.S162956","article-title":"Improving adherence to gout therapy: an expert review","volume":"14","author":"Perez-Ruiz","year":"2018","journal-title":"Ther Clin Risk Manag"},{"issue":"8","key":"10.1016\/j.semarthrit.2022.151988_bib0044","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1177\/1054773818791096","article-title":"Living with rheumatoid arthritis in Spain: a qualitative study of patient experience and the role of health professionals","volume":"29","author":"Pedraz-Marcos","year":"2020","journal-title":"Clin Nurs Res"},{"issue":"11","key":"10.1016\/j.semarthrit.2022.151988_bib0045","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1136\/annrheumdis-2013-203403","article-title":"The outcome and cost-effectiveness of nurse-led care in people with rheumatoid arthritis: a multicentre randomised controlled trial","volume":"73","author":"Ndosi","year":"2014","journal-title":"Ann Rheum Dis"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017222000397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017222000397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:07:55Z","timestamp":1758733675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017222000397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":45,"alternative-id":["S0049017222000397"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2022.151988","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Factors influencing clinician prescribing of disease-modifying anti-rheumatic drugs for inflammatory arthritis: A systematic review and thematic synthesis of qualitative studies","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2022.151988","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151988"}}